semaglutide and topiramate + Semaglutide: Safety & Personalized Dosing – PlexusDx Updated Meta-Analysis of Obesity Medications

Whether this elevated dosage could potentially increase the risk of acute pancreatitis in obese patients compared to those with diabetes is a subject that necessitates further investigation

Current pharmacological management faces substantial limitations, including poor bioavailability, systemic toxicity, narrow therapeutic indices, immunogenicity, and suboptimal patient adherence due to frequent dosing and adverse effects

Impaired phasic antral contractions are traditionally believed to be responsible for delayed emptying of solids in DGp, but other factors are also said to contribute

10.1093/cvr/cvae269 96 MoulinS.Blachot-MinassianB.KneppersA.ThomasA.ParadisS.BultotL.et al (2025)